Email page
Print page
Research Programs
Frontiers in Oncology Seminars
2012-2013 Seminars | 2011-2012 Seminars | 2010-2011 Seminars | 2009-2010 Seminars | 2008-2009 Seminars | 2007-2008 Seminars
2012 - 2013 Frontiers in Oncology Seminars
The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. It will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists, and research fellows.
| When: | 3rd Wednesday of every month, 8:00 a.m. |
| Where: | University of Maryland Health Science Facility II (HSF II) Auditorium |
| CME Credit: | One (1) Register online. |
| Contact: | 410-328-7516 |
September 12, 2012
Jacob M. Rowe M.D.
Director, Department of Hematology
Shaare Zedek Medical Center
Jerusalem
Interpreting Outcome Data on Transplantation for Adults with Acute Lymphoblastic Leukemia
From left: Dr. Kevin Cullen, Dr. Jacob M. Rowe and Dr. Aaron Rapoport (sponsor)
October 17, 2012
Gordon Mills, M.D., Ph.D.
University of Texas, MD Anderson Cancer Center
Division of Cancer Medicine
1515 Holcombe Blvd., Box 950
Houston, TX 77030
Functional Genomics: Drugging the Cancer Genome
From left to right: Gordon Mills, M.D., Ph.D.; Angela H. Brodie, Ph.D. (sponsor)
November 14, 2012
A. Thomas Look, M.D.
Vice Chair for Research
Department of Hematology/Oncology
Dana Farber Cancer Institute
Boston, MA 02115
Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine Activation of MET, Providing a Novel Therapeutic Target in Acute Myeloid Leukemia
From left: Dr. A. Thomas Look, Dr. Curt Civin (sponsor)
December 19, 2012 -- CANCELLED
Peter Sicinski, M.D., Ph.D.
Professor of Pathology
Harvard Medical School
Dana Farber Cancer Institute
450 Brookline Avenue; Smith 922A
Boston, M 02115
January 16, 2013
Carlos L. Arteaga, M.D.
Professor of Medicine and Cancer Biology
Division of Oncology/VUMC
2220 Pierce Avenue, 777 PRB
Nashville, TN 37232-6307
Neoadjuvant Trials in Breast Cancer: Role in Clinical Development and Discovery of Mechanisms of Drug Resistance
From left: Dr. Angela Brodie (sponsor), Dr. Carlos Arteaga, and Dr. Kevin Cullen
February 20, 2013
Warren S. Pear, M.D., Ph.D.
Department of Pathology
Abramson Family Cancer Research Institute
Perelman School of Medicine
University of Pennsylvania
Notch at the Interface of Leukemic Transformation and Lymphocyte Development
Dr. Curt Civin (sponsor)
March 20, 2013
Douglas R. Lowy, M.D.
NIH/NCI
Head, Signaling and Oncogenesis Section
Laboratory Chief
Bethesda, MD 20892
Toward the Prevention of HPV-Associated Cancer by HPV Vaccination
From left: Dr. Douglas Lowy, Dr. Kevin Cullen (sponsor)
April 17, 2013
Jean-Pierre Issa, M.D.
Professor of Medicine
Director, Fels Institute for Cancer and Molecular Biology
Temple University
Philadelphia, PA 19140
Epigenetic Reprogramming as Cancer Therapy
From left: Dr. Kevin Cullen, Dr. Jean-Pierre Issa, Dr. Feyruz Rassool
May 15, 2013
Steven A. Akman, M.D., Ph.D.
Professor , Hematology and Oncology
Wake Forest School of Medicine
Medical Center Blvd.
Winston-Salem, NC 27157
June 19, 2013
Jonathan D. Licht, M.D.
Professor and Chief
James B. Drew, MS, MBA, Division Administrator
Division of Hematology/Oncology
Northwestern University
Chicago, IL 60601
This page was last updated on: April 29, 2013.
Email this Page
Print this Page Physicians can call our dedicated consultation referral service at 1-800-373-4111.
22 S. Greene Street, Baltimore, MD 21201
